A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin

被引：0
|
作者：
Michal Witkowski
Lars Wilkinson
Neil Webb
Alan Weids
Divina Glah
Hrvoje Vrazic
机构：
[1] DRG Abacus,
[2] Novo Nordisk A/S,undefined
[3] Novo Nordisk Ltd.,undefined
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Basal insulin; GLP-1 receptor agonist; Glycemic control; HbA; Network meta-analysis; Semaglutide; Systematic review; Systolic blood pressure; Type 2 diabetes; Weight;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1233 / 1251
页数：18
相关论文
共 50 条
  • [11] Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 Diabetes
    Tuchscherer, Rhianna M.
    Thompson, Angela M.
    Trujillo, Jennifer M.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (12) : 1224 - 1232
  • [12] Comparing once-weekly semaglutide to incretin-based therapies in patients with type 2 diabetes: a systematic review and meta-analysis
    Mishriky, B. M.
    Cummings, D. M.
    Powell, J. R.
    Sewell, K. A.
    Tanenberg, R. J.
    DIABETES & METABOLISM, 2019, 45 (02) : 102 - 109
  • [13] ASSESSING CONSISTENCY IN A NETWORK META-ANALYSIS TO COMPARE ONCE WEEKLY DULAGLUTIDE VERSUS OTHER GLP-1 RECEPTOR AGONISTS IN PATIENTS WITH TYPE 2 DIABETES
    Hawkins, N.
    Padhiar, A.
    Thompson, J.
    Scott, D. A.
    Eaton, J. N.
    Varol, N.
    Norrbacka, K.
    Boye, K. S.
    Nicolay, C.
    VALUE IN HEALTH, 2014, 17 (07) : A335 - A335
  • [14] MODEL-BASED LONG-TERM COST-EFFECTIVENESS OF ONCE-WEEKLY SEMAGLUTIDE COMPARED WITH OTHER GLP-1 RECEPTOR AGONISTS IN TYPE 2 DIABETES: A SYSTEMATIC LITERATURE REVIEW
    Zhen, R.
    Shi, H.
    Yang, L.
    Hu, H.
    VALUE IN HEALTH, 2020, 23 : S509 - S509
  • [15] A review of GLP-1 receptor agonists in type 2 diabetes: A focus on the mechanism of action of once-weekly agents
    Cornell, Susan
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 : 17 - 27
  • [16] Efficacy and safety of once-weekly basal insulin versus once-daily basal insulin in patients with type 2 diabetes: A systematic review and meta-analysis
    Wang, Xinxin
    Xiao, Wei
    Liang, Zhanpeng
    Li, Shixiang
    Tang, Qizhi
    MEDICINE, 2023, 102 (52) : E36308
  • [17] Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis
    Solomon Nuhoho
    Jatin Gupta
    Brian Bekker Hansen
    Mary Fletcher-Louis
    Tam Dang-Tan
    Abby Paine
    Diabetes Therapy, 2019, 10 : 2183 - 2199
  • [18] Cardiovascular safety outcomes of once-weekly GLP-1 receptor agonists in people with type 2 diabetes
    Goldman, Jennifer D.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 : 61 - 72
  • [19] Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes Protocol for a systematic review and meta-analysis
    Shi, Fang-Hong
    Li, Hao
    Cui, Min
    Zhang, Zai-Li
    Gu, Zhi-Chun
    Liu, Xiao-Yan
    MEDICINE, 2018, 97 (16)
  • [20] Comparing once weekly GLP-1 receptor agonists for type 2 diabetes finds no clear winner
    McCarthy, Michael
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
12345